Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials-Reference-Cited by-同舟云学术

Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials

Published:2024-01 Issue: Volume:190 Page:110048
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Popp Ilinca,Vaes Rianne D.W.,Wieten Lotte,Adebahr Sonja,Hendriks Lizza,Bavafaye Haghighi Elham,Degens Juliette,Schäfer Henning,Greil Christine,Peeters Stéphanie,Waller Cornelius F.,Houben Ruud,Niedermann Gabriele,Rawluk Justyna,Gkika Eleni,Duyster Justus,Grosu Anca-Ligia,De Ruysscher Dirk

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference47 articles.

1. Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Hendriks;Ann Oncol,2023

2. Immunotherapy for non-small cell lung cancer: a new therapeutic algorithm;Berghmans;Eur Respir J,2020

3. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

4. Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC;Herbst;N Engl J Med,2020

5. Updated overall survival analysis from IMpower110: atezolizumab versus platinum-based chemotherapy in treatment-naive programmed death-ligand 1-selected NSCLC;Jassem;J Thorac Oncol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy;Cancer Immunology, Immunotherapy;2024-06-04

2. Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy;Cancers;2024-06-04

3. Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study;JTO Clinical and Research Reports;2024-05

4. Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer;International Journal of Molecular Sciences;2024-04-20